SHAB published 17 Jul 2026 · legal date 8 Jul 2026
Capital increase
●●○Likely financing
Paid in cash
Nominal capital
119’703.71 → 135’735.45
Shares
11’970’371 → 13’573’545
New shares, % of post-step shares
11.8% (1’603’174 new)
Aktienkapital neu: CHF 135'735.45 [bisher: CHF 119'703.71]. Liberierung Aktienkapital neu: CHF 135'735.45 [bisher: CHF 119'703.71]. Aktien neu: 13'573'545 Namenaktien zu CHF 0.01 [bisher: 11'970'371 Namenaktien zu CHF 0.01]. Die Gesellschaft hat mit Beschluss vom 08.07.2026 ein Kapitalband gemäss näherer Umschreibung in den Statuten beschlossen.
From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
The company was founded less than six years before this capital increase.+0.5
The company's purpose describes technology or life-sciences development.+0.5
Classifier score 0.82 · likely-financing threshold 0.60 · not a calibrated probability